Your browser doesn't support javascript.
loading
Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease.
Zaver, Shivam A; Sarkar, Mrinal K; Egolf, Shaun; Zou, Jonathan; Tiwaa, Afua; Capell, Brian C; Gudjonsson, Johann E; Simpson, Cory L.
  • Zaver SA; Division of Dermatology, Department of Medicine, and.
  • Sarkar MK; Medical Scientist Training Program, University of Washington, Seattle, Washington, USA.
  • Egolf S; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Zou J; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Tiwaa A; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Capell BC; Division of Dermatology, Department of Medicine, and.
  • Gudjonsson JE; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Simpson CL; Department of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
JCI Insight ; 8(18)2023 09 22.
Article en En | MEDLINE | ID: mdl-37561594
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Darier Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Darier Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2023 Tipo del documento: Article